跳至主要内容
临床试验/NCT05402618
NCT05402618已完成不适用

Minimally Invasive Versus Open Surgery for Perihilar Cholangiocarcinoma(PHC):A Multicenter Real-world Study

Renyi Qin1 个研究点 分布在 1 个国家目标入组 783 人开始时间: 2018年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
783
试验地点
1
主要终点
Postoperative length of stay

研究概览

简要总结

Brief Summary: This is a multicentric, retrospective, real-world study to investigate the surgical outcomes of minimally invasive surgery compared with open surgery for Perihilar Cholangiocarcinoma (PHC), with the perioperative characteristics and long-term overall survival being compared. We aimed to find out whether the minimally invasive surgery is safe or feasible for PHC. And we also want to find out patients with what kind of characteristic can be benefit from the minimally invasive surgery compared with the open approach.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Histologically confirmed PHC.

排除标准

  • Peritoneal seeding or metastasis to the liver, para-aortic lymph nodes, or distant sites;
  • Non-adenocarcinoma histology;
  • Incomplete clinical data.

结局指标

主要结局

Postoperative length of stay

时间窗: up to 90 days

defined as the time from being admitted to hospital to discharge

Overall survival

时间窗: through study completion, an average of 5 year

defined as the duration from the first day after surgery to either the date of death or the last follow-up

次要结局

  • Operation time(intraoperative)
  • Mortality(up to 90 days)
  • Operative details(intraoperative)
  • Intraoperative blood loss(intraoperative)
  • postoperative complications(up to 90 days)
  • Reoperation within 90 days(up to 90 days)
  • Readmission within 90 days(up to 90 days)
  • Vessel reconstruction(intraoperative)
  • R0 resection(intraoperative)

研究者

发起方
Renyi Qin
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Renyi Qin

Professor

Tongji Hospital

研究点 (1)

Loading locations...

相似试验